2021 House Bill 4357

Clarify definition of drug maker “gifts”

Introduced in the House

Feb. 24, 2021

Introduced by Rep. John Roth (R-104)

To clarify the definition of prohibited “gifts” from drug manufacturers or distributors to medical service providers.

Referred to the Committee on Health Policy

March 18, 2021

Reported without amendment

With the recommendation that the substitute (H-1) be adopted and that the bill then pass.

March 24, 2021

Passed in the House 102 to 5 (details)

Received in the Senate

March 25, 2021

Referred to the Committee on Health Policy and Human Services